ACTUALITES

Loulla&Philla (FP7)










Acronym: LOULLA & PHILLA

Title: Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children

Website



Start Date: 01.11.2008

Duration: 36 months

Project Cost: 4,3 millions €

Programme: FP7- Health

Topic: HEALTH-2007-4.2-1: Adapting off-patent medicines to the specific needs of paediatric populations


Consortium:

- Coordinator: Only for Children Pharmaceuticals (Contact Person: Vincent Grek)

- ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

- COPENHAGEN UNIVERSITY HOSPITAL

- Laboratoire Philippe DAVIOUD SAS

- HEINRICH-HEINE-UNIVERSITÄT DÜSSELDORF

- France Europe Innovation

- Cardinal Systems

- HOSPICES CIVILS DE LYON

- CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

Dernière mise à jour :
03/09/2017